GMP-compliant facilities
Our FDA-inspected, GMP-compliant facilities in California are optimized to meet the needs of our clients. The facility successfully completed a 2025 FDA inspection with no Form 483 observations issues. We continually expand and update our technical capabilities and have added services to support customers developing gene therapies and cell-based assays.




